15 Reasons we need new antimalarials

06 Jan 2015

As we count down to our 15th anniversary, each month we reflect on some of our favourite 15 things.

MMV’s R&D portfolio focuses on delivering efficacious medicines that are affordable, accessible and appropriate for use in malaria endemic areas. Here are 15 reasons we need new antimalarials.

  • Slideshow created January 2015

    Photo credits: Slide 1 - Lemu Golassa; Slide 2 - Feliciano Monti; Slide 3 - MMV; Slide 4 - MMV; Slide 5 - MMV; Slide 6 - MMV; Slide 7 - BMC St Jude; Slide 8 - Jennifer Jackson; Slide 9 - Merck Serono; Slide 10 - Anna Wang; Slide 11 - Ben Moldenhauer; Slide 12 - Anna Wang; Slide 13 - Anna Wang; Slide 14 - MMV; Slide 15 - MMV